Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Engineering macrophages for effective and safe targeting of CD47 cancer cells in the tumor microenvironment.
Journal: Journal for immunotherapy of cancer
Published: January 23, 2026
Oncolytic viruses targeting CD47: a new road to success?
Journal: Journal for immunotherapy of cancer
Published: April 18, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols.
Journal: Journal for immunotherapy of cancer
Published: February 05, 2025
Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies.
Journal: Frontiers in oncology
Published: August 28, 2019
Improving attribution of adverse events in oncology clinical trials.
Journal: Cancer treatment reviews
Published: April 23, 2019
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 28, 2019
The Macrophage 'Do not eat me' signal, CD47, is a clinically validated cancer immunotherapy target.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 29, 2019
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.
Journal: The New England journal of medicine
Published: November 01, 2018
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules.
Journal: Investigational new drugs
Published: February 22, 2018
Population pharmacokinetic analysis of oxaliplatin in adults and children identifies important covariates for dosing.
Journal: Cancer chemotherapy and pharmacology
Published: June 10, 2014
A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2013
Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data.
Journal: Journal of clinical pharmacology
Published: January 29, 2013
Last Updated: 09/26/2026